Seeking Alpha

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA...

Neoprobe (NEOP +4.8%) shares are higher today after submitting a new drug application to the FDA for its cancer detection platform Lymphoseek. The company seeks clearance to market it for use in surgical oncology procedures.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)